StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Perspective Therapeutics's market cap was $94.14M on Nov 11, 2026, against $174.69M a year earlier. Over the last 5 years it ranged from $32.66M to $1.07B, with a median of $169.03M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$94.14M-53.9%
2025Dec 31, 2025$204.43M-5.1%
2024Dec 31, 2024$215.53M+277.5%
2023Dec 29, 2023$57.10M+60.8%
2022Dec 30, 2022$35.51M-35.5%
2021Dec 31, 2021$55.03M+77.5%
2020Dec 31, 2020$31.00M-26.3%
2019Dec 31, 2019$42.08M+108.3%
2018Dec 31, 2018$20.20M-8.1%
2017Dec 29, 2017$21.97M-31.1%
2016Dec 30, 2016$31.91M-38.3%
2015Dec 31, 2015$51.71M-35.5%
2014Dec 31, 2014$80.13M+317.1%
2013Dec 31, 2013$19.21M-28.8%
2012Dec 31, 2012$26.99M+54.3%
2011Dec 30, 2011$17.49M–

More Perspective Therapeutics figures

See a number that looks wrong?